Some of the CT legislation include a menopause provider toolkit, research funding for endometriosis and coverage for IUDs.
CSL has surged 35.5% since early June, clearing key moving averages despite little fundamental change. Is the battered biotech giant staging a comeback?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results